“…This practice was particularly common in India. 15 While such broad screening may provide valuable information in patients in or from TB endemic regions, 2,3,8,25 and is recommended for patients with suggestive clinical features as described above 9 and prior to initiating long-term immunosuppression -particularly with tumor necrosis factor (TNF)-a inhibitors, 26 its routine use in low-risk populations use has been called into question. 27 Moreover, in both developed and developing countries, the vast majority of respondents indicated that the presence of either radiographic or immunologic evidence of prior MTB exposure would prompt them to initiate ATT, even in the absence of suggestive clinical findings.…”